Escalon Medical Corp. ESMC
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 48.01% | -27.37% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 48.01% | -27.37% | |||
| Cost of Revenue | 15.22% | -18.35% | |||
| Gross Profit | 105.57% | -39.16% | |||
| SG&A Expenses | -6.19% | 0.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.74% | -13.31% | |||
| Operating Income | 235.58% | -524.82% | |||
| Income Before Tax | -72.95% | 2,329.27% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -24.94% | 2,329.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -24.94% | 2,329.27% | |||
| EBIT | 235.58% | -524.82% | |||
| EBITDA | 237.28% | -488.34% | |||
| EPS Basic | -26.06% | 2,657.63% | |||
| Normalized Basic EPS | 245.82% | -552.44% | |||
| EPS Diluted | -26.80% | 2,657.63% | |||
| Normalized Diluted EPS | 242.11% | -552.38% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 2.36% | 0.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||